tradingkey.logo

Gyre Therapeutics Inc <GYRE.OQ> expected to post earnings of 3 cents a share - Earnings Preview

ReutersMay 5, 2025 11:17 AM
  • Gyre Therapeutics Inc GYRE.OQ GYRE.O is expected to report resultson May 7 (estimated) for the period ending March 31 2025

  • The San Diego California-based company is expected to report revenue of $28.4 million, according to the estimate from one analyst, based on LSEG data.

  • ​LSEG's mean analyst estimate for Gyre Therapeutics Inc is for earnings of 3 cents per share.

  • The one available analyst rating on the shares is "buy".

  • The average consensus recommendation for the biotechnology & medical research peer group is also "Buy".​

  • Wall Street's median 12-month price target for Gyre Therapeutics Inc is $20.00​, above​ its last closing price of $9.26. ​​​

This summary was machine generated May 5 at 11:17 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI